{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:57:36Z","timestamp":1789498656386,"version":"build-2803163510"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197096","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T13:30:45Z","timestamp":1528723845000},"page":"e0197096","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-3018","authenticated-orcid":true,"given":"Hassan","family":"Salmanroghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Mirvakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmud","family":"Baghbanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham","family":"Salmanroghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golshid","family":"Sanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Yazdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"issue":"s1","key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.2002.0160s1003.x","article-title":"Natural history and epidemiology of Helicobacter pylori infection","volume":"16","author":"M Go","year":"2002","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"1","key":"ref2","first-page":"2","article-title":"Helicobacter pylori in Iran: A systematic review on the antibiotic resistance","volume":"18","author":"F Khademi","year":"2015","journal-title":"Iranian journal of basic medical sciences"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta\u2010analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first\u2010line therapies for Helicobacter pylori","volume":"26","author":"L Fischbach","year":"2007","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"10","key":"ref4","article-title":"Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China","volume":"25","author":"H Lu","year":"2013","journal-title":"European journal of gastroenterology & hepatology"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"DY Graham","year":"2010","journal-title":"Gut"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/mdr.2014.0081","article-title":"Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran","volume":"21","author":"L Shokrzadeh","year":"2015","journal-title":"Microbial Drug Resistance"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/mdr.2014.0104","article-title":"The helicobacter pylori resistance rate to clarithromycin in Iran","volume":"21","author":"S KeshavarzAziziRaftar","year":"2015","journal-title":"Microbial Drug Resistance"},{"issue":"45","key":"ref8","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.3748\/wjg.v16.i45.5746","article-title":"Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran","volume":"16","author":"S Farshad","year":"2010","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"DY Graham","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2036.2004.02248.x","article-title":"Meta\u2010analysis: the efficacy, adverse events, and adherence related to first\u2010line anti\u2010Helicobacter pylori quadruple therapies","volume":"20","author":"L Fischbach","year":"2004","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1365-2036.2002.01278.x","article-title":"One\u2010week triple vs. quadruple therapy for Helicobacter pylori infection\u2014a randomized trial","volume":"16","author":"X Calvet","year":"2002","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jcp.41.2.207","article-title":"Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies","volume":"41","author":"C Goodwin","year":"1988","journal-title":"Journal of clinical pathology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1572-0241.2003.t01-1-07288.x","article-title":"Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial","volume":"98","author":"L Laine","year":"2003","journal-title":"The American journal of gastroenterology"},{"issue":"6","key":"ref14","first-page":"987","article-title":"Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran","volume":"49","author":"AT Abadi","year":"2011","journal-title":"Journal of microbiology (Seoul, Korea)"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jac\/47.4.459","article-title":"Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea","volume":"47","author":"JJ Kim","year":"2001","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1523-5378.2000.00011.x","article-title":"Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil","volume":"5","author":"S Mendonca","year":"2000","journal-title":"Helicobacter"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori","volume":"26","author":"L A Fischbach","year":"2007","journal-title":"Aliment PharmacolTher"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cgh.2008.10.024","article-title":"Efficient identification and evaluation of effective Helicobacter pylori therapies","volume":"7","author":"DY Graham","year":"2009","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"suppl 1","key":"ref19","doi-asserted-by":"crossref","first-page":"I40","DOI":"10.1136\/gut.45.2008.i40","article-title":"Treatment after failure: the problem of \u201cnon-responders\u201d","volume":"45","author":"J Huang","year":"1999","journal-title":"Gut"},{"issue":"30","key":"ref20","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.3748\/wjg.v20.i30.10355","article-title":"Helicobacter pylori eradication in West Asia: a review","volume":"20","author":"H Fakheri","year":"2014","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1440-1746.2003.03058.x","article-title":"Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori","volume":"18","author":"HS Roghani","year":"2003","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"1","key":"ref22","first-page":"89","article-title":"Survey in Iran of clarithromycin resistance in Helicobacter pylori isolates by PCR-RFLP","volume":"44","author":"N Sadeghifard","year":"2013","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"4","key":"ref23","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"V De Francesco","year":"2010","journal-title":"Journal of Gastrointestinal & Liver Diseases"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"CA Fallone","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/apt.12808","article-title":"Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori","volume":"40","author":"J Delchier","year":"2014","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1365-2036.2002.01368.x","article-title":"Eradication rates of clarithromycin\u2010resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin","volume":"16","author":"K Murakami","year":"2002","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cgh.2013.01.008","article-title":"Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study","volume":"11","author":"X Liang","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1523-5378.2012.00962.x","article-title":"Greater than 95% success with 14\u2010day bismuth quadruple anti\u2010helicobacter pylori therapy: a pilot study in US Hispanics","volume":"17","author":"CO Salazar","year":"2012","journal-title":"Helicobacter"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00042737-199907000-00004","article-title":"Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and Its resistant strains","volume":"11","author":"HS Roghani","year":"1999","journal-title":"European journal of gastroenterology & hepatology"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study","volume":"14","author":"D Graham","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"MP Dore","year":"2016","journal-title":"Gut"},{"key":"ref32","article-title":"Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis","author":"AC Ford","journal-title":"World journal of gastr"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cgh.2014.10.036","article-title":"High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection","volume":"13","author":"J-C Yang","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"ref34","first-page":"448","article-title":"High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study","volume":"28","author":"A Zullo","year":"2015","journal-title":"Annals of gastroenterology: quarterly publication of the Hellenic Society of Gastroenterology"},{"issue":"40","key":"ref35","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.3748\/wjg.v16.i40.5118","article-title":"Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World journal of gastroenterology","volume":"16","author":"Q-J Sun","year":"2010","journal-title":"WJG"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/AAC.39.8.1859","article-title":"Bactericidal and morphological effects of amoxicillin on Helicobacter pylori","volume":"39","author":"V Berry","year":"1995","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dkn051","article-title":"Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori","volume":"61","author":"E Rimbara","year":"2008","journal-title":"Journal of antimicrobial chemotherapy"},{"issue":"18","key":"ref38","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.3748\/wjg.v20.i18.5283","article-title":"Treatment of Helicobacter pylori infection: current status and future concepts. World Journal of Gastroenterology","volume":"20","author":"J-C Yang","year":"2014","journal-title":"WJG"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/gut.2007.132514","article-title":"Helicobacter pylori and antibiotic resistance","volume":"56","author":"F Megraud","year":"2007","journal-title":"Gut"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","article-title":"Antibiotic resistance of Helicobacter pylori among male United States veterans","volume":"13","author":"S Shiota","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"38","key":"ref41","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.3748\/wjg.v11.i38.6009","article-title":"Helicobacter pylori antibiotic resistance in Iran","volume":"11","author":"M Mohammadi","year":"2005","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"3","key":"ref42","first-page":"177","article-title":"Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies","volume":"13","author":"S Massarrat","year":"2010","journal-title":"Archives of Iranian medicine"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"e17791","DOI":"10.17795\/ijep17791","article-title":"Antibacterial resistance patterns of helicobacter pyloriclinical isolates from gastric biopsy of patients in yazd","volume":"2","author":"T Navidifar","year":"2014","journal-title":"Int J Enteric Pathog"},{"key":"ref44","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy","author":"W Zhang","year":"2015","journal-title":"Gut"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T11:55:06Z","timestamp":1540209306000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197096"}},"subtitle":[],"editor":[{"given":"John","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197096","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.mdjc24n","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]}}}